Introduction
Paroxetine hydrochloride (PRX), (3S-trans)-3-[(1,3-benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride, is a potent selective seratonin (5-hydroxy tryptamine) reuptake inhibitor (SSRI) currently used as an antidepressant drug. Its metabolism and pharmacokinetics in humans have been extensively studied. 1 Its chemical structure is shown in Fig. 1 .
Some analytical methods, such as HPLC, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] HPLC-GC, 13 GC, 14 GC-MS 15 and capillary liquid chromatography 16 have been reported for PRX in biological fluids and pharmaceutical dosage forms.
Flow injection analysis (FIA) is a new methodology characterized by its versatility, ease of automation, high sampling frequency and minimum sample treatment prior to injection into the system. The FIA techniques have recently found wide applications, mainly due to a reduction of the analysis time and the consumption of reagents compared to conventional manual procedures. 17 They can also optimize the detection of analyte independently from the routine process occurring in the chromatographic column. 18 The aim of this study was a direct determination of PRX by FIA (method) and application to pharmaceutical preparations.
Experimental

Apparatus and chemicals
A Model LC 6A pump equipped with a 20 µL manual loop injector, a Model SPD-A10 UV variable wavelength detector and a Model C-R7A integrator (all Shimadzu, Japan) were used for FIA measurements. A Shimadzu spectrophotometer (Model UV 2401 PC, Japan) and quartz cells in the measurement of the absorbance were used to measure the absorbance in batchwise operations. The analytical wavelength was 293 nm, and the area under the curve (AUC) was used for the calibration and measurement. A Model WTW Multiline P4 Universal pHmeter with a Sen-Tix 92T pH electrode was employed for pH measurements of the solution.
Standard PRX (hydrochloride, 99.8%) and tablets (Seroxat ® ) containing 20 mg of active material were kindly supplied from Novartis Health, Food and Agriculture Products A. Ş. 80640 Istanbul, Turkey. Other chemicals were of analytical grade (E. Merck).
Solutions
A stock solution of PRX (1.07 × 10 -3 mol dm -3 ) was prepared using EtOH (10%, v/v). Standard solutions in the concentration range of 1.07 × 10 -6 -5.35 × 10 -6 mol dm -3 were made from the stock solution. As a mobile phase, an aqueous solution of MeOH (10%, v/v) was used. The buffer solutions were prepared using 1 mol dm -3 CH3COONa (pH 1 -6) and 1 mol dm -3 K2HPO4 (pH 7 -11), and their pH values were adjusted using 1 mol dm -3 HCl or 1 mol dm -3 KOH.
Application to tablets
Ten tablets were weighed and finely powdered in a mortar (The average weight of a tablet was calculated). For the FIA, the standard PRX equivalent to one tablet and 1 ml acetate buffer (1 mol dm -3 , pH 3.07) was transferred to a 100 ml calibrated flask, which was magnetically stirred for 20 min and made up to volume with bi-distilled water. A sufficient amount of the solution was pipetted in a tube and centrifuged for 10 min. The supernatant was diluted with distilled water to predetermined values and injected into the sample loop by means of a syringe. A flow-injection analysis (FIA) of paroxetine hydrochloride (PRX), a selective serotonin reuptake inhibitor (SSRI) currently used as an antidepressant drug, is described. A 0.1 mol dm -3 acetate buffer at pH 3.07 was found to be the best solvent. The analyte was detected at 293 nm. The calibration equation was linear over the range of 1.07 × 10 -6 to 5.35 × 10 -6 mol dm -3 . The limit of detection (LOD) and the limit of quantitation (LOQ) were 3.2 × 10 -7 and 9.5 × 10 -7 mol dm -3 , respectively. The proposed method was applied to the determination of PRX in pharmaceutical preparations. The results were compared with those obtained by a conventional batchwise UV-spectrophotometry. 
Results and Discussion
The percentage of MeOH in the carrier phase (10 -50%, v/v) was investigated. It was found that the optimum concentration of MeOH, in view of the peak morphology, was 10% (v/v). The flow-rate of the carrier was changed from 0.2 cm 3 min -1 to 3.0 cm 3 min -1 , and 1.5 cm 3 min -1 was found to be the best (The final concentration of the buffer in the test solution was 0.1 mol dm -3 ). Morphologically good peak areas versus the pH were obtained at around pH 3. The differences in the peak area were minimum at pH values ranging from 1 to 6, as shown in Fig. 2 .
The AUC values for PRX show great differences between pH 6 and 7. It is thought that this pH range corresponds to the pKa value of PRX (6.17). 19 Therefore, a pH 3.07 buffer was used for the determination. The signals of PRX (1.07 × 10 -6 -5.35 × 10 -6 mol dm -3
) were obtained under the conditions described above, and are shown in Fig. 3 .
Although the prepared solutions gave the same signals for one week, it was not always possible to obtain the true stability of the molecule.
The relationship between the area under the curve (AUC) and the PRX concentration was found to be AUC = 1.80 × 10 9 C (mol dm -3 ) + 1551.7; r = 0.9999. The limit of detection (LOD, S/N = 3) and the limit of quantitation (LOQ, S/N = 10) were 3.2 × 10 -7 mol dm -3 with RSD = 1.22% and 9.5 × 10 -7 mol dm -3 with RSD = 1.03% (n = 8), respectively (The results indicated that this method was highly precise and reproducible).
The repeatability and reproducibility of the system was examined by injecting 3.21 × 10 -6 mol dm -3 of PRX. The results concerning the area under the curve (AUC) are listed in Table 1 .
The linearity and accuracy in the concentration range of 1.07 × 10 -6 -5.35 × 10 -6 mol dm -3 were examined by employing intra-day and inter-day (for three days) studies for the determination of PRX. Very accurate results were obtained for intra-day and inter-day experiments with good correlation, as shown in Table 2 . Thus, the present FIA method could be used for the analysis of PRX.
Application to pharmaceutical dosage forms
The proposed technique was applied to pharmaceutical dosage forms containing 20 mg PRX.
Batchwise UVspectrophotometry was chosen as a comparison method for the determination of PRX.
The relationship between the absorbance (A) and the concentration (C) was found to be A =3755.1C (mol dm -3 ) + 0.0011, r = 0.9999. The validity of this method was examined by applying to commercial tablets. The ingredients in the tablets did not interfere with the experiments. It was observed that the ingredients in the tablets showed no UV absorbance at a working wavelength of 293 nm. All results of the assay were evaluated statistically, as presented in Table 3 . High reproducibility and insignificant differences between FIA and UV-spectrophotometry were observed at the p = 0.05 (95%) probability level (Table 3 ). In conclusion, the proposed method is simple, accurate, precise, and rapid. Therefore, the suggested method is more practical regarding the time of analysis, consumption of solvents and size of the sample required for a routine analysis of PRX.
